Charles Farkas

CIK: 0001615538

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (25.0%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CNMD

CONMED Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

CNMD
CONMED Corp
Jun 2, 2026
Exercise(M)
Direct
668 shares-
CNMD
CONMED Corp
Jun 1, 2026
Award(A)
RSUs (Restricted Stock Units)
Direct
5.8K shares-
CNMD
CONMED Corp
Sep 12, 2025
Sale(S)
Direct
897 shares at avg. $53.51$48K
CNMD
CONMED Corp
Sep 12, 2025
Sale(S)
Direct
1.1K shares at avg. $53.53$59K
CNMD
CONMED Corp
Jun 3, 2025
Exercise(M)
Direct
479 shares-
CNMD
CONMED Corp
Jun 2, 2025
Award(A)
RSUs (Restricted Stock Units)
Direct
668 shares-
CNMD
CONMED Corp
Jun 2, 2025
Award(A)
Options To Purchase Common Stock
Direct
8.1K shares-
CNMD
CONMED Corp
May 29, 2025
Exercise(M)
Direct
1K shares at avg. $55.70$56K
CNMD
CONMED Corp
May 29, 2025
Tax Payment(F)
Direct
966 shares at avg. $57.69$56K
CNMD
CONMED Corp
May 5, 2025
Sale(S)
Direct
4K shares at avg. $56.94$228K
CNMD
CONMED Corp
Sep 5, 2024
Tax Payment(F)
Direct
534 shares at avg. $74.31$40K
CNMD
CONMED Corp
Sep 5, 2024
Exercise(M)
Direct
1K shares at avg. $39.64$40K

		Type	Shares	Price		Ownership
Jun 2, 2026	CNMD CONMED Corp	Exercise(M)	668	-	$0	Direct
Jun 1, 2026	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	5,772	-	-	Direct
Sep 12, 2025	CNMD CONMED Corp	Sale(S)	897	$53.51	$48,000	Direct
Sep 12, 2025	CNMD CONMED Corp	Sale(S)	1,103	$53.53	$59,049	Direct
Jun 3, 2025	CNMD CONMED Corp	Exercise(M)	479	-	-	Direct
Jun 2, 2025	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	668	-	-	Direct
Jun 2, 2025	CNMD CONMED Corp	Award(A) Options To Purchase Common Stock	8,061	-	-	Direct
May 29, 2025	CNMD CONMED Corp	Exercise(M)	1,000	$55.70	$55,700	Direct
May 29, 2025	CNMD CONMED Corp	Tax Payment(F)	966	$57.69	$55,729	Direct
May 5, 2025	CNMD CONMED Corp	Sale(S)	4,000	$56.94	$227,768	Direct
Sep 5, 2024	CNMD CONMED Corp	Tax Payment(F)	534	$74.31	$39,682	Direct
Sep 5, 2024	CNMD CONMED Corp	Exercise(M)	1,000	$39.64	$39,640	Direct

1-12 of 12 transactions

About Farkas Charles

Farkas Charles (SEC CIK 0001615538) files insider reports with the SEC as Director of CONMED Corp (CNMD).

Signal8 holds 6 ownership filings by Farkas Charles, all Form 4s, filed between Sep 9, 2024 and Jun 3, 2026. Those filings report 12 transactions, from Sep 5, 2024 to Jun 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Farkas Charles's filings is in LARGO, FL.

Recent filings by Farkas Charles

Jun 2, 2026: Option exercise of CNMD shares (Form 4, code M).
Jun 1, 2026: Grant or award of CNMD derivative securities (Form 4, code A).
Sep 12, 2025: Open-market sales of CNMD shares (2 lines, Form 4, code S).
Jun 3, 2025: Option exercise of CNMD shares (Form 4, code M).
Jun 2, 2025: Grants or awards of CNMD derivative securities (2 lines, Form 4, code A).

Other insiders filing for CONMED Corp (CNMD)

Kelderman Kim, Director
Gallagher John E, Executive Vice President & CFO
Martin Celine Christine, Director
Mirviss Jeffrey B., Director
Bronson David M., Director
Council LaVerne H, Director

How to read Form 4 transaction codes